PUREfi Wealth’s AbbVie ABBV Stock Holding History

PUREfi Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.32M	Buy	5,232 +161	+3%	+$34.6K	0.72%	32
2026 Q1	$1.1M	Sell	5,071 -993	-16%	-$220K	0.72%	31
2025 Q4	$1.39M	Buy	6,064 +36	+0.6%	+$8.2K	1.06%	22
2025 Q3	$1.4M	Buy	6,028 +199	+3%	+$40.5K	1.07%	19
2025 Q2	$1.08M	Buy	5,829 +878	+18%	+$163K	0.87%	27
2025 Q1	$1.04M	Buy	4,951 +1,995	+67%	+$388K	1.04%	17
2024 Q4	$525K	Buy	+2,956	New	+$543K	0.51%	49

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

PUREfi Wealth's ABBV Position: Q2 2026 in Review

PUREfi Wealth increased its AbbVie (ABBV) stake by 3.2% in Q2 2026, buying an estimated $34.6K and bringing the position to 5,232 shares worth $1.32M. The position accounts for 0.72% of the portfolio, ranked #32.

PUREfi Wealth first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.4M in Q3 2025. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

PUREfi Wealth held 5,232 shares of AbbVie worth $1.32M as of Q2 2026.
PUREfi Wealth bought 161 AbbVie shares in Q2 2026, an estimated $34.6K.
AbbVie made up 0.72% of PUREfi Wealth's portfolio in Q2 2026, its #32 holding.
PUREfi Wealth first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
PUREfi Wealth's AbbVie position peaked at $1.4M in Q3 2025.
4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on PUREfi Wealth's 13F filing for Q2 2026, filed 27 Jul 2026.